About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Sirolimus Market Size, Growth & Share | Forecast-2031 |
Sirolimus Market

Sirolimus Market Size, Share & Trends Analysis Report By Strength (5mg, 1mg, 2mg, 1mg/mL), By Application (Organ Transplant Rejection, Sirolimus Catheter Device, Sirolimus Coated Balloons, Others), By Drug Class (mTOR Inhibitors, Selective Immunosuppressants), By Dosage (Injection, Tablet, Others), By Route of Administration (Oral, Intravenous, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH55947DR
Last Updated : Mar 19, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Sirolimus Market Introduction
    2. By Strength
      1. Introduction
        1. Strength By Value
      2. 5mg
        1. By Value
      3. 1mg
        1. By Value
      4. 2mg
        1. By Value
      5. 1mg/mL
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Organ Transplant Rejection
        1. By Value
      3. Sirolimus Catheter Device
        1. By Value
      4. Sirolimus Coated Balloons
        1. By Value
      5. Others
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. mTOR Inhibitors
        1. By Value
      3. Selective Immunosuppressants
        1. By Value
    5. By Dosage
      1. Introduction
        1. Dosage By Value
      2. Injection
        1. By Value
      3. Tablet
        1. By Value
      4. Others
        1. By Value
    6. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Intravenous
        1. By Value
      4. Others
        1. By Value
    7. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Strength
      1. Introduction
        1. Strength By Value
      2. 5mg
        1. By Value
      3. 1mg
        1. By Value
      4. 2mg
        1. By Value
      5. 1mg/mL
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Organ Transplant Rejection
        1. By Value
      3. Sirolimus Catheter Device
        1. By Value
      4. Sirolimus Coated Balloons
        1. By Value
      5. Others
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. mTOR Inhibitors
        1. By Value
      3. Selective Immunosuppressants
        1. By Value
    5. By Dosage
      1. Introduction
        1. Dosage By Value
      2. Injection
        1. By Value
      3. Tablet
        1. By Value
      4. Others
        1. By Value
    6. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Intravenous
        1. By Value
      4. Others
        1. By Value
    7. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    8. U.S.
      1. By Strength
        1. Introduction
          1. Strength By Value
        2. 5mg
          1. By Value
        3. 1mg
          1. By Value
        4. 2mg
          1. By Value
        5. 1mg/mL
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Organ Transplant Rejection
          1. By Value
        3. Sirolimus Catheter Device
          1. By Value
        4. Sirolimus Coated Balloons
          1. By Value
        5. Others
          1. By Value
      3. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. mTOR Inhibitors
          1. By Value
        3. Selective Immunosuppressants
          1. By Value
      4. By Dosage
        1. Introduction
          1. Dosage By Value
        2. Injection
          1. By Value
        3. Tablet
          1. By Value
        4. Others
          1. By Value
      5. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral
          1. By Value
        3. Intravenous
          1. By Value
        4. Others
          1. By Value
      6. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Homecare
          1. By Value
        5. Others
          1. By Value
    9. Canada
    1. Introduction
    2. By Strength
      1. Introduction
        1. Strength By Value
      2. 5mg
        1. By Value
      3. 1mg
        1. By Value
      4. 2mg
        1. By Value
      5. 1mg/mL
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Organ Transplant Rejection
        1. By Value
      3. Sirolimus Catheter Device
        1. By Value
      4. Sirolimus Coated Balloons
        1. By Value
      5. Others
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. mTOR Inhibitors
        1. By Value
      3. Selective Immunosuppressants
        1. By Value
    5. By Dosage
      1. Introduction
        1. Dosage By Value
      2. Injection
        1. By Value
      3. Tablet
        1. By Value
      4. Others
        1. By Value
    6. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Intravenous
        1. By Value
      4. Others
        1. By Value
    7. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    8. U.K.
      1. By Strength
        1. Introduction
          1. Strength By Value
        2. 5mg
          1. By Value
        3. 1mg
          1. By Value
        4. 2mg
          1. By Value
        5. 1mg/mL
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Organ Transplant Rejection
          1. By Value
        3. Sirolimus Catheter Device
          1. By Value
        4. Sirolimus Coated Balloons
          1. By Value
        5. Others
          1. By Value
      3. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. mTOR Inhibitors
          1. By Value
        3. Selective Immunosuppressants
          1. By Value
      4. By Dosage
        1. Introduction
          1. Dosage By Value
        2. Injection
          1. By Value
        3. Tablet
          1. By Value
        4. Others
          1. By Value
      5. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral
          1. By Value
        3. Intravenous
          1. By Value
        4. Others
          1. By Value
      6. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Homecare
          1. By Value
        5. Others
          1. By Value
    9. Germany
    10. France
    11. Spain
    12. Italy
    13. Russia
    14. Nordic
    15. Benelux
    16. Rest of Europe
    1. Introduction
    2. By Strength
      1. Introduction
        1. Strength By Value
      2. 5mg
        1. By Value
      3. 1mg
        1. By Value
      4. 2mg
        1. By Value
      5. 1mg/mL
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Organ Transplant Rejection
        1. By Value
      3. Sirolimus Catheter Device
        1. By Value
      4. Sirolimus Coated Balloons
        1. By Value
      5. Others
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. mTOR Inhibitors
        1. By Value
      3. Selective Immunosuppressants
        1. By Value
    5. By Dosage
      1. Introduction
        1. Dosage By Value
      2. Injection
        1. By Value
      3. Tablet
        1. By Value
      4. Others
        1. By Value
    6. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Intravenous
        1. By Value
      4. Others
        1. By Value
    7. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    8. China
      1. By Strength
        1. Introduction
          1. Strength By Value
        2. 5mg
          1. By Value
        3. 1mg
          1. By Value
        4. 2mg
          1. By Value
        5. 1mg/mL
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Organ Transplant Rejection
          1. By Value
        3. Sirolimus Catheter Device
          1. By Value
        4. Sirolimus Coated Balloons
          1. By Value
        5. Others
          1. By Value
      3. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. mTOR Inhibitors
          1. By Value
        3. Selective Immunosuppressants
          1. By Value
      4. By Dosage
        1. Introduction
          1. Dosage By Value
        2. Injection
          1. By Value
        3. Tablet
          1. By Value
        4. Others
          1. By Value
      5. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral
          1. By Value
        3. Intravenous
          1. By Value
        4. Others
          1. By Value
      6. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Homecare
          1. By Value
        5. Others
          1. By Value
    9. Korea
    10. Japan
    11. India
    12. Australia
    13. Singapore
    14. Taiwan
    15. South East Asia
    16. Rest of Asia-Pacific
    1. Introduction
    2. By Strength
      1. Introduction
        1. Strength By Value
      2. 5mg
        1. By Value
      3. 1mg
        1. By Value
      4. 2mg
        1. By Value
      5. 1mg/mL
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Organ Transplant Rejection
        1. By Value
      3. Sirolimus Catheter Device
        1. By Value
      4. Sirolimus Coated Balloons
        1. By Value
      5. Others
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. mTOR Inhibitors
        1. By Value
      3. Selective Immunosuppressants
        1. By Value
    5. By Dosage
      1. Introduction
        1. Dosage By Value
      2. Injection
        1. By Value
      3. Tablet
        1. By Value
      4. Others
        1. By Value
    6. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Intravenous
        1. By Value
      4. Others
        1. By Value
    7. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    8. UAE
      1. By Strength
        1. Introduction
          1. Strength By Value
        2. 5mg
          1. By Value
        3. 1mg
          1. By Value
        4. 2mg
          1. By Value
        5. 1mg/mL
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Organ Transplant Rejection
          1. By Value
        3. Sirolimus Catheter Device
          1. By Value
        4. Sirolimus Coated Balloons
          1. By Value
        5. Others
          1. By Value
      3. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. mTOR Inhibitors
          1. By Value
        3. Selective Immunosuppressants
          1. By Value
      4. By Dosage
        1. Introduction
          1. Dosage By Value
        2. Injection
          1. By Value
        3. Tablet
          1. By Value
        4. Others
          1. By Value
      5. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral
          1. By Value
        3. Intravenous
          1. By Value
        4. Others
          1. By Value
      6. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Homecare
          1. By Value
        5. Others
          1. By Value
    9. Turkey
    10. Saudi Arabia
    11. South Africa
    12. Egypt
    13. Nigeria
    14. Rest of MEA
    1. Introduction
    2. By Strength
      1. Introduction
        1. Strength By Value
      2. 5mg
        1. By Value
      3. 1mg
        1. By Value
      4. 2mg
        1. By Value
      5. 1mg/mL
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Organ Transplant Rejection
        1. By Value
      3. Sirolimus Catheter Device
        1. By Value
      4. Sirolimus Coated Balloons
        1. By Value
      5. Others
        1. By Value
    4. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. mTOR Inhibitors
        1. By Value
      3. Selective Immunosuppressants
        1. By Value
    5. By Dosage
      1. Introduction
        1. Dosage By Value
      2. Injection
        1. By Value
      3. Tablet
        1. By Value
      4. Others
        1. By Value
    6. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Intravenous
        1. By Value
      4. Others
        1. By Value
    7. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    8. Brazil
      1. By Strength
        1. Introduction
          1. Strength By Value
        2. 5mg
          1. By Value
        3. 1mg
          1. By Value
        4. 2mg
          1. By Value
        5. 1mg/mL
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Organ Transplant Rejection
          1. By Value
        3. Sirolimus Catheter Device
          1. By Value
        4. Sirolimus Coated Balloons
          1. By Value
        5. Others
          1. By Value
      3. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. mTOR Inhibitors
          1. By Value
        3. Selective Immunosuppressants
          1. By Value
      4. By Dosage
        1. Introduction
          1. Dosage By Value
        2. Injection
          1. By Value
        3. Tablet
          1. By Value
        4. Others
          1. By Value
      5. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral
          1. By Value
        3. Intravenous
          1. By Value
        4. Others
          1. By Value
      6. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Homecare
          1. By Value
        5. Others
          1. By Value
    9. Mexico
    10. Argentina
    11. Chile
    12. Colombia
    13. Rest of LATAM
    1. Sirolimus Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Accord Healthcare (US)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Apotex Inc. (Canada)
    3. and Amneal Pharmaceuticals LLC. (US)
    4. Pfizer Inc. (US)
    5. Zydus Cadila (India)
    6. Dr. Reddy's Laboratories Ltd. (India)
    7. Torrent Pharmaceuticals Ltd. (India)
    8. Biocon (India)
    9. Concept Medical (US)
    10. Intas Pharmaceuticals Ltd (India)
    11. Concord Biotech (India)
    12. Livzon (China)
    13. Actiza Pharmaceutical Private Limited (India)
    14. Tiefenbacher API + Ingredients GmbH & Co. KG (Germany)
    15. Delphis Pharmaceutical (India).
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
Buy Now
Global Report
The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.